Current Report Filing (8-k)
02 Marzo 2022 - 9:14AM
Edgar (US Regulatory)
0001500123
false
Item 9 Labs Corp.
DE
0001500123
2022-03-02
2022-03-02
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
PURSUANT
TO SECTION 13 OR 15(d) OF THE
SECURITIES
EXCHANGE ACT OF 1934
Date
of Report: March 2, 2022
ITEM
9 LABS CORP.
(Exact
name of registrant as specified in its charter)
| Delaware |
|
000-54730 |
|
96-0665018 |
| (State of other jurisdiction |
|
(Commission |
|
(IRS Employer |
| of incorporation) |
|
File Number) |
|
Identification No.) |
2727
N 3rd Street, Suite
201, Phoenix
AZ
85004
(Address of principal executive offices and zip code)
1-833-867-6337
(Registrant’s
telephone number, including area code)
N/A
(Former
name or former address, if changed since last report)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions (see General Instruction A.2. below):
☐
Written communications pursuant to Rule 425 under the Securities Act
(17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17
CFR 240.14a -12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange
Act (17 CFR 240.14d -2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange
Act (17 CFR 240.13e -4(c))
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth
company. ☐
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Securities
registered pursuant to Section 12(b) of the Act:
| Title
of each class |
|
Trading
Symbol(s) |
|
Name
of each exchange on which registered |
| |
|
|
|
|
| Item 5.02 |
Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers; |
Shane
Evans – Appointment
The biography
for Ms. Evans is below:
On March 1,
2022, the Board appointed Ms. Shane Evans as an independent member of the Company’s Board of Directors.
Ms. Evans, 52,
brings a diverse perspective to the boardroom combining her involvement in the health and wellness industry with her entrepreneurship,
strategic growth, and franchising history to deliver thoughtful questions and insights that help drive informed decisions. As a C-level
executive, founder, and entrepreneur with more than 20 years of business experience, she spearheaded the growth of Massage Heights from
infancy to more than 120 retreats throughout North America. Ms. Evans is also the Co-owner of several Massage Heights retail locations;
Co-owner of the supply chain, Summit Franchise Supply, LLC; Co-owner of The Gents Place, an ultra-premium men's grooming franchise brand;
and is on the Board of Directors of the Massage Heights Family Fund, a 501c3 crisis fund for team members in need. She has also been a
dedicated member of the Young Presidents Organization (YPO) alongside Bowden since 2015, serves on the International Franchise Association’s
(IFA) Franchise Relations Committee and is an active member of the Franchisor Forum.
Family Relationships
Ms. Evans is
not related to any Officer or Director of the Company.
Related Party Transactions
There are no related party
transactions reportable under Item 5.02 of Form 8-K and Item 404(a) of Regulation S-K.
| Item 7.01 |
Regulation FD Disclosure. |
Attached hereto as Exhibit 99.1 is a press
release we issued on March 2, 2022, announcing the appointment of Shane Evans to the Company’s Board of Directors.
| Item 9.01 |
Financial Statements and Exhibits. |
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
| |
ITEM 9 LABS CORP. |
| |
|
|
| Dated: March
2, 2022 |
By: |
/s/ Robert
Mikkelsen |
| |
|
Robert Mikkelsen |
| |
|
Chief Financial Officer |
Item 9 Labs (CE) (USOTC:INLB)
Gráfica de Acción Histórica
De Nov 2024 a Dic 2024
Item 9 Labs (CE) (USOTC:INLB)
Gráfica de Acción Histórica
De Dic 2023 a Dic 2024
